Spine
Barricaid annular closure device reduces reherniation rate after discectomy for lumbar herniation
Spine J. 2018 Dec;18(12):2278-2287. doi: 10.1016/j.spinee.2018.05.003554 patients with a lumbar disc herniation, large annular defect, and scheduled for lumbar discectomy were randomized to the surgery with or without additional intervention using an annular closure device (Barricaid; Intrinsic Therapeutics). Patients were followed primary for the incidence of re-herniation and composite endpoints of success over the first 2 years after surgery. Results demonstrated a significantly lower rate of subsequent symptomatic lumbar disc re-herniation at the index level among the group treated with the annular closure device. In addition, the ACD group also demonstrated significantly higher rates of success using the primary composite endpoint and modified clinical composite endpoint.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
